Your session is about to expire
← Back to Search
Topotecan for Brain Tumor
Study Summary
This trial is testing an alternative method of delivering Topotecan directly into brain tumors to see if it is safe and well tolerated.
- Brain Tumor
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 3 trial • 444 Patients • NCT03061812Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could you please provide a synopsis of prior experiments involving Topotecan?
"Currently, 61 ongoing Topotecan clinical trials are underway with 17 in the third and final phase. A majority of these studies occur in Saint Louis, Missouri but an impressive 3195 centres across America have active research for this medication."
What conditions is Topotecan typically prescribed to treat?
"Topotecan is a common treatment for ovarian cancer and can also alleviate the symptoms of acute myelocytic leukemia, sarcoma, and other malignant neoplasms."
How many subjects is this research project recruiting?
"Affirmative. As indicated by clinicaltrials.gov information, this medical trial is currently recruiting participants and has been since June 20th 2019. The study requires approximately 5 patients who can be found at one single site."
Is recruitment currently open for this trial?
"Data hosted on clinicaltrials.gov reveals that recruitment for this medical trial is still ongoing; the initial posting was made on June 20th 2019 and has been recently updated as of August 10th 2022."
Share this study with friends
Copy Link
Messenger